Keyphrases
Gastric Cancer
100%
Microsatellite Instability-high (MSI-H)
81%
Tumor
65%
Hereditary Colorectal Cancer Syndromes
39%
Loss of Heterozygosity
34%
Gastric Carcinoma
33%
E-cadherin
30%
Neoadjuvant
25%
Carcinoma
25%
Germline mutation
25%
5-fluorouracil (5-FU)
21%
Polymorphism
21%
MLH1
19%
Colorectal Cancer
19%
Neoadjuvant Chemotherapy
19%
Hereditary Diffuse Gastric Cancer
18%
Upper Gastrointestinal Tract
17%
Mutation Carriers
16%
Gastric Cancer Patients
15%
Germ Cells
15%
Cisplatin
15%
Chemotherapy
14%
MSH2
14%
Overall Survival
13%
Diffuse-type Gastric Cancer
13%
Remnant Gastric Cancer
12%
Prognostic Impact
12%
E-cadherin mutations
12%
Epidermal Growth Factor Receptor
12%
CDH1
12%
TP53 mutation
11%
CDH1 mutation
11%
Non-associated
11%
Cyclin D1 (CCND1)
11%
Cetuximab
11%
Genotype
10%
Microsatellites
10%
Esophageal Adenocarcinoma
10%
E-cadherin Gene
10%
Immunohistochemistry
10%
Adenocarcinoma
9%
Cancer Families
9%
Response Prediction
9%
MSH6
9%
Adenoma
9%
Chromosomal Instability
9%
Response to Neoadjuvant Chemotherapy
9%
Allelic Loss
8%
Gene Expression
8%
Neoadjuvant Therapy
8%
Biochemistry, Genetics and Molecular Biology
Microsatellite Instability
60%
Loss of Heterozygosity
34%
Microsatellite
33%
Cadherin
32%
Germline Mutation
30%
MLH1
23%
Overall Survival
20%
Cisplatin
19%
Genetics
19%
MSH2
18%
P53
16%
Upper Digestive Tract
16%
DNA Mismatch Repair
16%
Fluorouracil
15%
Promoter Region
15%
Colon
14%
Germline
14%
Germ Cell
14%
Carcinogenesis
12%
Methylation
11%
Genomics
11%
Genotyping
11%
Exon
11%
Esophagus
11%
Gene Expression
11%
Epidermal Growth Factor Receptor
11%
KRAS
9%
Gene Mutation
8%
MSH6
8%
Chromosome Instability
8%
Cyclin D1
8%
DNA Repair
7%
Oncogene
7%
Tumor Suppressor Gene
7%
Messenger RNA
7%
Thymidylate Synthase
6%
Genetic Predisposition
6%
Allelic Imbalance
6%
Genetic Heterogeneity
6%
Protein P53
6%
Cell Adhesion Proteins
6%
Real-Time Polymerase Chain Reaction
6%
Drug Resistance
5%
Cancer Cell
5%
MUTYH
5%
Epimutation
5%
Oxidoreductase
5%
Missense Mutation
5%
Epstein Barr Virus
5%
Mutation Rate
5%
Medicine and Dentistry
Abdominal Cancer
61%
Tumor
38%
Microsatellite Instability
26%
Hereditary Nonpolyposis Colorectal Cancer
21%
Carcinoma
19%
Germline Mutation
18%
Colorectal Carcinoma
18%
Stomach Carcinoma
17%
Neoplasm
17%
Neoadjuvant Chemotherapy
15%
Protein P53
15%
Adenocarcinoma
14%
Heterozygosity
13%
Uvomorulin
13%
Malignant Neoplasm
12%
Overall Survival
12%
Diseases
12%
Adenoma
10%
Biological Marker
10%
DNA Mismatch Repair
9%
Prognostic Factor
8%
Cisplatin
8%
Hereditary Diffuse Gastric Cancer
8%
Colon Carcinoma
8%
Gene Expression
7%
Exon
7%
Cancer
7%
Immunohistochemistry
7%
Gastrectomy
7%
Carcinogenesis
7%
Upper Digestive Tract
6%
Biopsy Technique
6%
Neuroendocrine Carcinoma
6%
Esophageal Adenocarcinoma
6%
Chromosomal Instability
6%
Methylation
5%
Stomach Adenocarcinoma
5%
Hereditary Colorectal Cancer
5%
Recurrent Disease
5%
Oxidoreductase
5%
Breast Carcinoma
5%
Histone Deacetylase 2
5%
HDAC1
5%
Cyclin D1
5%
Medicine
5%
Germ Cell
5%
Hazard Ratio
5%
Treatment Response
5%
